Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,465–3,472 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
RAPT Therapeutics Inc. Zelnecirnon (RPT193) Atopic dermatitis Phase 2b Trial Discontinued Oral Immunology
RAPT Therapeutics Inc. Ozureprubart (RPT904) Asthma Phase 2 Ongoing Intravenous Respiratory
RAPT Therapeutics Inc. RPT904 Chronic spontaneous urticaria (CSU) Phase 2 Ongoing oral Immunology
RAPT Therapeutics Inc. tivumecirnon (FLX475) in combination with pembrolizumab Advanced Cancer Phase 2 Data Released Intravenous Oncology
Recursion Pharmaceuticals Inc. REC-2282 - (POPLAR-NF2) Neurofibromatosis Type 2 Phase 2/3 Trial Discontinued oral Genetic Disorder
Recursion Pharmaceuticals Inc. REC-394 C. difficile Phase 2 Ongoing Oral Antibiotic
Recursion Pharmaceuticals Inc. REC-3964 Difficile Colitis Phase 2 Ongoing Oral Gastroenterology
Recursion Pharmaceuticals Inc. REC-3599 GM2 Gangliosidosis Phase 2 Ongoing Intravenous Genetic Disorder